002391.SZ
Changqing (Hubei) Biotechnology Co., Ltd.
SZSE · Basic Materials · C 制造业 · CN
CNY 5.10
+0.20%Year over year
Reported trailing growth
- Revenue
- +5.0%
- EBITDA
- —
- EBIT
- +143.3%
- EPS
- +150.4%
- Free cash flow
- +106.6%
- Operating cash flow
- +237.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -4.6%
- EBITDA
- -9.2%
- EBIT
- -47.6%
- Net income
- -46.3%
- EPS
- -45.6%
- Free cash flow
- +97.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026